SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+2.97%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.24B
AUM Growth
+$1.24B
(-6.3%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-2.21%
Top 10 Holdings %
Top 10 Hldgs %
21.29%
Holding
139
New
26
Increased
28
Reduced
58
Closed
12
Top Buys
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$24.3M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$23.4M |
| 3 |
Aveanna Healthcare
AVAH
|
$20.5M |
| 4 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
$19.9M |
| 5 |
AGTI
Agiliti, Inc.
AGTI
|
$18.1M |
Top Sells
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
$32.3M |
| 2 |
Novavax
NVAX
|
$21.8M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$17.2M |
| 4 |
Arvinas
ARVN
|
$14.4M |
| 5 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$13.1M |
Sector Composition
| 1 | Healthcare | 94.02% |
| 2 | Industrials | 4.68% |
| 3 | Financials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Hologic
HOLX
$14.7B
| $6.43M | 0.52% |
96,300
-66,500
| -41% | -$4.44M |
|
77
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.07M | 0.49% |
72,722
-14,750
| -17% | -$1.23M |
|
78
Icon
ICLR
$14B
| $5.94M | 0.48% |
+28,750
| New | +$5.94M |
|
79
Merck
MRK
$210B
| $5.85M | 0.47% |
+75,250
| New | +$5.85M |
|
80
Tenet Healthcare
THC
$16.5B
| $5.69M | 0.46% |
+85,000
| New | +$5.69M |
|
81
Cigna
CI
$80.2B
| $5.67M | 0.46% |
23,897
-2,400
| -9% | -$569K |
|
82
Natera
NTRA
$23B
| $5.66M | 0.46% |
49,850
-79,000
| -61% | -$8.97M |
|
|
SWAV
83
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $5.31M | 0.43% |
+28,000
| New | +$5.31M |
|
84
Thermo Fisher Scientific
TMO
$183B
| $5.25M | 0.42% |
10,400
| – | – |
|
|
FRLN
85
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $5.22M | 0.42% |
640,714
-13,784
| -2% | -$112K |
|
86
Denali Therapeutics
DNLI
$2.24B
| $5.1M | 0.41% |
65,000
+61,000
| +1,525% | +$4.79M |
|
87
Boston Scientific
BSX
$159B
| $4.96M | 0.4% |
115,976
+13,250
| +13% | +$567K |
|
|
ONCR
88
DELISTED
Oncorus, Inc.
ONCR
| $4.62M | 0.37% |
335,000
| – | – |
|
89
Danaher
DHR
$143B
| $4.5M | 0.36% |
16,775
| – | – |
|
|
VIRX
90
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.49M | 0.36% |
395,739
-251,817
| -39% | -$2.86M |
|
|
FNCH
91
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $4.23M | 0.34% |
300,399
-89,601
| -23% | -$1.26M |
|
92
Bolt Biotherapeutics
BOLT
$9.29M
| $3.96M | 0.32% |
256,187
-63,823
| -20% | -$987K |
|
|
BLU
93
DELISTED
BELLUS Health Inc.
BLU
| $3.9M | 0.32% |
1,252,940
-22,000
| -2% | -$68.4K |
|
94
Alpha Teknova
TKNO
$227M
| $3.77M | 0.31% |
+159,060
| New | +$3.77M |
|
95
Stryker
SYK
$149B
| $3.56M | 0.29% |
13,700
| – | – |
|
|
CMPI
96
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $3.23M | 0.26% |
541,766
| – | – |
|
97
Amgen
AMGN
$153B
| $3.21M | 0.26% |
13,153
-8,150
| -38% | -$1.99M |
|
98
Tandem Diabetes Care
TNDM
$834M
| $3.13M | 0.25% |
32,100
-3,000
| -9% | -$292K |
|
99
Moderna
MRNA
$9.36B
| $2.97M | 0.24% |
12,650
-3,200
| -20% | -$752K |
|
100
Monte Rosa Therapeutics
GLUE
$309M
| $2.94M | 0.24% |
+129,633
| New | +$2.94M |
|